VOYA Investment Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,197
Closed -$71K 2830
2021
Q1
$71K Hold
1,197
﹤0.01% 2713
2020
Q4
$45K Buy
1,197
+399
+50% +$14.9K ﹤0.01% 2665
2020
Q3
$43K Hold
798
﹤0.01% 2441
2020
Q2
$201K Sell
798
-299
-27% -$60.4K ﹤0.01% 2155
2020
Q1
$172K Buy
1,097
+75
+7% +$12.7K ﹤0.01% 2178
2019
Q4
$167K Buy
1,022
+205
+25% +$30.3K ﹤0.01% 2430
2019
Q3
$119K Hold
817
﹤0.01% 2370
2019
Q2
$170K Buy
817
+89
+12% +$19.1K ﹤0.01% 2345
2019
Q1
$152K Hold
728
﹤0.01% 2339
2018
Q4
$128K Hold
728
﹤0.01% 2350
2018
Q3
$165K Hold
728
﹤0.01% 2396
2018
Q2
$110K Hold
728
﹤0.01% 2505
2018
Q1
$133K Hold
728
﹤0.01% 2426
2017
Q4
$155K Buy
728
+65
+10% +$13.9K ﹤0.01% 2414
2017
Q3
$142K Hold
663
﹤0.01% 2474
2017
Q2
$125K Buy
+663
New +$130K ﹤0.01% 2530

Other funds holding CRBP

VOYA Investment Management's CRBP Position: Q2 2021 in Review

VOYA Investment Management sold out of Corbus Pharmaceuticals (CRBP) in Q2 2021, closing a stake of 1,197 shares — an estimated $71K sold.

VOYA Investment Management first reported a position in CRBP in Q2 2017 and held it in 16 quarters. The position peaked at $201K in Q2 2020. 98 funds tracked by Wall St. Rank hold CRBP as of Q2 2021.

  • VOYA Investment Management reported no remaining Corbus Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • VOYA Investment Management sold 1,197 Corbus Pharmaceuticals shares in Q2 2021, an estimated $71K.
  • VOYA Investment Management first reported a position in Corbus Pharmaceuticals in Q2 2017 and held it in 16 quarters.
  • VOYA Investment Management's Corbus Pharmaceuticals position peaked at $201K in Q2 2020.
  • 98 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2021.

Based on VOYA Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.